Clinical Trials Browser

Recruiting × Solid Tumors × Clear all

NCT05101070 2026-03-18

aCCeleR8-001

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT05203172 2026-03-18

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Phase 4 Recruiting

Other solid neoplasm

Solid Tumors

NCT05155332 2026-03-17

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06892379 2026-03-13

A Study of HS-20110 in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07018622 2026-03-11

DAPA-ARMOR

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT04589845 2026-03-06

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Phase 2 Recruiting

920 enrolled 1 FDA

Other solid neoplasm

Solid Tumors

NCT03347318 2026-03-04

PROFILING

Other solid neoplasm

Solid Tumors

NCT07030959 2026-02-25

Study of AUBE00 in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07181681 2026-02-23

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06651593 2026-02-17

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07123103 2026-02-17

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06885281 2026-02-13

A Study of ZL-1310 in Participants With Selected Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07351903 2026-01-20

GUARDIAN-02

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07312903 2026-01-12

DPTX3186 in Wnt Pathway Activated Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07265622 2025-12-29

First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06227377 2025-12-24

QTX3034 in Patients With KRAS G12D Mutation

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT05836324 2025-12-18

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06727812 2025-12-18

Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT05471856 2025-12-17

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07159126 2025-12-10

A Study of DS3610a in Participants With Advanced Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07274085 2025-12-10

A Phase 1 Study of HDM2017 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07105215 2025-11-26

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07032077 2025-11-20

A Phase II Clinical Trial on the Safety, Tolerability, and Efficacy of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors.

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07231081 2025-11-17

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07055594 2025-11-06

NbTAST-01

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06805461 2025-10-15

PanTheR

Other solid neoplasm

Solid Tumors

NCT06066424 2025-10-14

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07158918 2025-09-08

ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT04685226 2025-09-02

A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06826313 2025-07-18

A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06410131 2025-07-01

Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06963281 2025-06-06

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06710379 2025-04-09

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06816992 2025-03-20

ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC

Phase 1 Recruiting

Other solid neoplasmThoracic

Solid Tumors

NCT06764628 2025-01-22

A Study of SHR-4375 in Subjects With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT05650242 2024-11-08

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06233292 2024-06-14

A Study of ZG005 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT03744819 2024-02-06

Biomarkers for Prediction of Tumor Response to Radiotherapy

Other solid neoplasm

Solid Tumors